CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Smith Kline & French Laboratories Limited v. Teva Pharmaceuticals USA Inc.

1:05-cv-00197

Overview

Case Number 1:05-cv-00197
Filing Date 2005-04-06
Status Terminated
Termination Date 2007-03-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

4 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

300 Delaware Avenue, Suite 1120, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0700

300 Delaware Avenue, Suite 1120, Wilmington, DE 19801

Josy W. Ingersoll

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Monte Terrell Squire

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 571-6713
Fax: +1 (302) 576-3515

ADDRESS EXPIRED / UNKNOWN, (302) 571-6713

SmithKline Beecham Corporation NPE (University / Research)

Represented By

1 Attorneys Listed

Patricia Smink Rogowski

Panitch Schwarze Belisario & Nadel LLP

Tel: +1 (302) 394-6030

Applied Bank Center, 2200 Concord Pike, Suite 201

Plaintiff

Smith Kline & French Laboratories Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Patricia Smink Rogowski

Panitch Schwarze Belisario & Nadel LLP

Tel: +1 (302) 394-6030

Applied Bank Center, 2200 Concord Pike, Suite 201

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): πŸ‡¨πŸ‡¦ Canada πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US4452808
4-Aminoalkyl-2(3H)-indolones
Filed: 1982-12-07
Issued: 1984-06-05
Expired (Term Ended) +1826d PTA
Expires: 2007-12-07
US4824860
Treatment of Parkinsons disease
Filed: 1988-05-19
Issued: 1989-04-25
Expired (Term Ended)
Expires: 2008-05-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1826 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

2

Denied

0

Pending / Review

0

Motions by Category

Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Granted
ORDER granting 30 Claim Construction Chart and proposed Stipulated Order on Claim Construction, filed by Teva Pharmaceuticals USA Inc., SmithKline Beecham Corpo...
Entry #31 • 2006-03-01 Document →
Claim Construction / Markman Filing Pending
CLAIM Construction Chart by Teva Pharmaceuticals USA Inc., Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation, Smith Kline & French Labor...
Entry #30 • 2006-02-23 Document →
Claim Construction / Markman Filing Granted
CLAIM Construction Chart by Teva Pharmaceuticals USA Inc., Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation, Smith Kline & French Labor...
Entry #30 • 2006-02-23 Document →

Docket Entries

(44 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 138752.) - filed by Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation. (Attachments: # 1 Civil Cover Sheet # 2 Acknowledgement of Consent Form)(mwm, ) (Entered: 04/07/2005)

Entry #1 • 2005-04-06
1
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 138752.) - filed by Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation. (Attachments: # 1 Civil Cover Sheet # 2 Acknowledgement of Consent Form)(mwm, ) (Entered: 04/07/2005)

Entry #1 • 2005-04-06
2
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 138752.) - filed by Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation. (Attachments: # 1 Civil Cover Sheet # 2 Acknowledgement of Consent Form)(mwm, ) (Entered: 04/07/2005)

Entry #1 • 2005-04-06
2

Disclosure Statement pursuant to Rule 7.1 filed by Smith Kline & French Laboratories Limited, SmithKline Beecham Corporation identifying GlaxoSmithKline plc as Corporate Parent. (mwm, ) (Entered: 04/07/2005)

Entry #2 • 2005-04-06
1

Report to the Commissioner of Patents for Patent Number(s) 4,452,808; 4,824,860; (mwm, ) (Entered: 04/07/2005)

Entry #3 • 2005-04-06
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc